 Precancerous Conditions
"Precancerous Conditions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)
| Descriptor ID |
D011230
|
| MeSH Number(s) |
C04.834
|
| Concept/Terms |
Precancerous Conditions- Precancerous Conditions
- Condition, Precancerous
- Conditions, Precancerous
- Precancerous Condition
Condition, Preneoplastic- Condition, Preneoplastic
- Preneoplastic Condition
- Preneoplastic Conditions
- Conditions, Preneoplastic
|
Below are MeSH descriptors whose meaning is more general than "Precancerous Conditions".
Below are MeSH descriptors whose meaning is more specific than "Precancerous Conditions".
This graph shows the total number of publications written about "Precancerous Conditions" by people in UAMS Profiles by year, and whether "Precancerous Conditions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2021 | 3 | 0 | 3 | | 2020 | 2 | 2 | 4 | | 2019 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2017 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2015 | 0 | 2 | 2 | | 2014 | 2 | 1 | 3 | | 2013 | 2 | 2 | 4 | | 2012 | 2 | 0 | 2 | | 2011 | 2 | 0 | 2 | | 2010 | 3 | 3 | 6 | | 2009 | 1 | 1 | 2 | | 2008 | 6 | 0 | 6 | | 2007 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2005 | 4 | 0 | 4 | | 2004 | 2 | 1 | 3 | | 2003 | 1 | 0 | 1 | | 2002 | 0 | 3 | 3 | | 2000 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 1997 | 1 | 1 | 2 | | 1996 | 0 | 1 | 1 | | 1992 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 | | 1989 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Precancerous Conditions" by people in Profiles over the past ten years.
-
Bui CM, Pukhalskaya T, Smoller BR, Zengin HB, Heneidi S, Vail E, Makhoul E, Balzer B. Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection. J Cutan Pathol. 2023 Jun; 50(6):568-576.
-
Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, Rosa-Cunha I, Arons A, Pugliese JC, Vena D, Sparano JA, Wilkin TJ, Bucher G, Stier EA, Tirado Gomez M, Flowers L, Barroso LF, Mitsuyasu RT, Lensing SY, Logan J, Aboulafia DM, Schouten JT, de la Ossa J, Levine R, Korman JD, Hagensee M, Atkinson TM, Einstein MH, Cracchiolo BM, Wiley D, Ellsworth GB, Brickman C, Berry-Lawhorn JM. Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. N Engl J Med. 2022 06 16; 386(24):2273-2282.
-
Montgomery EA, Arnold CA, Lam-Himlin DM, McDonald OG, Poveda JC, Salimian KJ, Voltaggio L, Waters KM, Wood LD, Singhi AD. Some Morphology Frontiers of Dysplasia in the Tubular Gastrointestinal Tract: The Rodger C. Haggitt Memorial Lecture. Am J Surg Pathol. 2022 01 01; 46(1):e1-e14.
-
Cuzick J, Du R, Adcock R, Kinney W, Joste N, McDonald RM, English K, Torres SM, Saslow D, Wheeler CM. Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States. Gynecol Oncol. 2021 09; 162(3):555-559.
-
Williamson SR, Al-Obaidy KI, Cheng L, Smith SC, Cox RM, McKenney JK, Gokden N, Phillips CL, Giannico GA, Gallan AJ, Przybycin CG, Grignon DJ. Distal Tubular Hyperplasia: A Proposal for a Unique Form of Renal Tubular Proliferation Distinct From Papillary Adenoma. Am J Surg Pathol. 2021 04 01; 45(4):516-522.
-
Klair JS, Zafar Y, Nagra N, Murali AR, Jayaraj M, Singh D, Rustagi T, Krishnamoorthi R. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis. Dig Dis. 2021; 39(6):561-568.
-
Demkowicz R, Thota PN, Benjamin T, Lopez R, Lu H, Patil DT, Downs-Kelly E, Jeung JA, Lai KK, Lapinski J, Savage EC, Goldblum JR, Gordon IO. Allaying uncertainty in diagnosing buried Barrett's esophagus. Ann Diagn Pathol. 2021 Apr; 51:151672.
-
Maura F, Landgren O, Morgan GJ. Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma. Clin Cancer Res. 2021 01 01; 27(1):15-23.
-
Garg S, Xie J, Inamdar S, Thomas SL, Trindade AJ. Spatial distribution of dysplasia in Barrett's esophagus segments before and after endoscopic ablation therapy: a meta-analysis. Endoscopy. 2021 01; 53(1):6-14.
-
Mundo AI, Greening GJ, Fahr MJ, Hale LN, Bullard EA, Rajaram N, Muldoon TJ. Diffuse reflectance spectroscopy to monitor murine colorectal tumor progression and therapeutic response. J Biomed Opt. 2020 03; 25(3):1-16.
-
Mallinger WD, Quick CM. Benign and Premalignant Lesions of the Endometrium. Surg Pathol Clin. 2019 Jun; 12(2):315-328.
-
Alshelleh M, Inamdar S, McKinley M, Stewart M, Novak JS, Greenberg RE, Sultan K, Devito B, Cheung M, Cerulli MA, Miller LS, Sejpal DV, Vegesna AK, Trindade AJ. Incremental yield of dysplasia detection in Barrett's esophagus using volumetric laser endomicroscopy with and without laser?marking compared with a standardized random biopsy?protocol. Gastrointest Endosc. 2018 07; 88(1):35-42.
-
Campbell JP, Heaney JLJ, Pandya S, Afzal Z, Kaiser M, Owen R, Child JA, Gregory W, Morgan GJ, Jackson GH, Bunce CM, Drayson MT. Active multiple myeloma suppresses and typically eliminates coexisting MGUS. Br J Cancer. 2017 Sep 05; 117(6):835-839.
-
Trindade AJ, Inamdar S, Kothari S, Berkowitz J, McKinley M, Kaul V. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus. Dig Endosc. 2017 Sep; 29(6):680-685.
-
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani SZ, Choyke PL, Kurdziel K, Landgren O. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging. Leuk Lymphoma. 2016 May; 57(5):1114-21.
-
Heidor R, de Conti A, Ortega JF, Furtado KS, Silva RC, Tavares PE, Purgatto E, Ract JN, de Paiva SA, Gioielli LA, Pogribny IP, Moreno FS. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis. Mol Nutr Food Res. 2016 Feb; 60(2):420-9.
-
Joiner AK, Quick CM, Jeffus SK. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems. Int J Gynecol Pathol. 2015 Jan; 34(1):40-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|